Victoza 6 mg

VICTOZA 6 MG is a subcutaneous solution containing liraglutide, used for managing type 2 diabetes. This medication supports blood sugar control and is available in 1, 2, or 3 pen packs.

VICTOZA 6 MG is primarily used to improve glycemic control in adults with type 2 diabetes. It works by mimicking natural hormones in the body to lower blood sugar levels. This medication is often part of a comprehensive diabetes management plan, which may include diet and exercise.

Common effects of VICTOZA 6 MG may include nausea, vomiting, diarrhea, constipation, and injection site reactions. Some users may also experience decreased appetite or fatigue. These effects vary and are not experienced by everyone.

VICTOZA 6 MG should be used with caution in individuals with a history of pancreatitis or severe gastrointestinal disease. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always store the pens properly to maintain their effectiveness.

VICTOZA 6 MG may interact with other medications, including those that affect blood sugar levels or stomach emptying. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.